Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferrlecit for maintenance of iron stores in pediatric hemodialysis patients
NCT00224003Phase 4Completed
- Sponsor
- Watson Pharmaceuticals
- Start
- Apr 2003
- Primary completion
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sodium ferric gluconate in anemia, sponsored by Watson Pharmaceuticals. Primary endpoints: Serum Ferritin at 14 weeks and Transferrin Saturation at 14 weeks. Started Apr 2003; status: completed.
02
Drugs
sodium ferric gluconate
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00224003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00224003.